Efficacy News and Research

RSS
Zidesamtinib shows strong activity in TKI-naive ROS1-positive non-small cell lung cancer

Zidesamtinib shows strong activity in TKI-naive ROS1-positive non-small cell lung cancer

Ris-Rez improves survival in patients with relapsed small-cell lung cancer

Ris-Rez improves survival in patients with relapsed small-cell lung cancer

European registry shows continued improvements in cataract surgery outcomes

European registry shows continued improvements in cataract surgery outcomes

Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC

Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC

Neoadjuvant atezolizumab addition quadruples pathological responses in resectable lung tumors

Neoadjuvant atezolizumab addition quadruples pathological responses in resectable lung tumors

Low discontinuation rates confirm manageable safety of iza-bren

Low discontinuation rates confirm manageable safety of iza-bren

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

Early studies hint that ketones may affect pathways linked to PTSD

Early studies hint that ketones may affect pathways linked to PTSD

Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosis

Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosis

Tizanidine looked promising early in a migraine trial, but the benefit did not last

Tizanidine looked promising early in a migraine trial, but the benefit did not last

Why researchers are looking at psilocybin for repeated mild head injuries

Why researchers are looking at psilocybin for repeated mild head injuries

Early B-cell therapy linked to better MS disease control

Early B-cell therapy linked to better MS disease control

Study links methylglyoxal stress to immunotherapy resistance in triple-negative cancer

Study links methylglyoxal stress to immunotherapy resistance in triple-negative cancer

Digital companion apps help secure long-term habits during GLP-1 therapy

Digital companion apps help secure long-term habits during GLP-1 therapy

Study shows how the microbiome shapes lung cancer immunotherapy outcomes

Study shows how the microbiome shapes lung cancer immunotherapy outcomes

Vitamin A derivative prevents immune cell exhaustion in brain tumors

Vitamin A derivative prevents immune cell exhaustion in brain tumors

Advancing intracellular delivery with LumiPore®: A new approach to cell transfection and drug discovery

Advancing intracellular delivery with LumiPore®: A new approach to cell transfection and drug discovery

Could scorpion venom inspire new treatments for liver disease?

Could scorpion venom inspire new treatments for liver disease?

The vaginal microbiome may be an overlooked reservoir of antibiotic resistance

The vaginal microbiome may be an overlooked reservoir of antibiotic resistance

GLP-1 drugs looked promising for depression. The evidence tells a more complicated story

GLP-1 drugs looked promising for depression. The evidence tells a more complicated story

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.